This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.
Hideaki Umemoto, PhD, General Manager at Fujimoto Chemicals Co., Ltd., discusses the advantages of Fujimat as a standalone liquid phase synthesis reagent that can selectively remove itself at the TIDES USA conference in San Diego, Calif. He also explains the benefits of amidite blocks, such as reducing the production burden and shortening the production time for oligonucleic acids.
